Axon Enterprise
AXON
#472
Rank
NZ$87.47 B
Marketcap
NZ$1,101
Share price
3.05%
Change (1 day)
7.50%
Change (1 year)

Earnings for Axon Enterprise (AXON)

Earnings in 2025 (TTM): NZ$0.41 Billion

According to Axon Enterprise 's latest financial reports the company's current earnings are NZ$2.55 Billion. In 2024 the company made an earning of NZ$0.67 Billion, an increase over its 2023 earnings that were of NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Axon Enterprise from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.41 B-38.24%
2024 NZ$0.67 B147.92%
2023 NZ$0.27 B68.08%
2022 NZ$0.16 B-155.47%
2021 -NZ$0.3 Billion1088.15%
2020 -NZ$24.67 Million121.3%
2019 -NZ$11.15 Million-125.74%
2018 NZ$43.3 M90.75%
2017 NZ$22.7 M-59.11%
2016 NZ$55.52 M-9.86%
2015 NZ$61.59 M8.71%
2014 NZ$56.66 M10.67%
2013 NZ$51.19 M43.35%
2012 NZ$35.71 M-402.97%
2011 -NZ$11.79 Million33.15%
2010 -NZ$8.86 Million6315.17%
2009 -NZ$0.14 Million-100.45%
2008 NZ$30.45 M-14.25%
2007 NZ$35.51 M-474.06%
2006 -NZ$9.5 Million-449.46%
2005 NZ$2.71 M-94.95%
2004 NZ$53.82 M307.28%
2003 NZ$13.21 M1999.86%
2002 NZ$0.62 M-63.88%
2001 NZ$1.74 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
XBiotech
XBIT
-NZ$50.12 Million-112.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-NZ$0.14 Billion-133.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.2 Billion-146.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.52 B 268.45%๐Ÿ‡บ๐Ÿ‡ธ USA